Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Beckman Coulter, Inc.
WARNING LETTER
•Beckman Coulter, Inc.•June 2, 2011

Beckman Coulter, Inc. – FDA Warning Letter, Jun 2, 2011

Record Details

On November 1, 2011, the FDA issued a Warning Letter to Beckman Coulter, Inc. following an inspection from February 28, 2011, to June 2, 2011, at their Miami, FL facility, which manufactures Class I and II in vitro diagnostic products. The inspection revealed that the devices are adulterated under 21 U.S.C. § 351(h) due to non-conformity with Current Good Manufacturing Practice (CGMP) requirements of the Quality System regulation (21 CFR Part 820).

Key violations include: 1. **Failure to establish and maintain adequate procedures for implementing corrective and preventive action (CAPA)** (21 CFR 820.100(a)). Specific issues included inadequate failure investigations, failure to extend CAPA investigations to assess OEM quality systems, conflicting information in failure investigations, and failure to implement established procedures for supplier corrective actions. The adequacy of the firm's responses regarding CAPA procedures could not be determined without evidence of implementation. 2. **Failure to establish and maintain adequate procedures for receiving, reviewing, and evaluating complaints** (21 CFR 820.198(a)). Not all customer feedback investigations included required information, and many lacked documented investigation results or proper determination of the need for CAPA. Complaint investigation results also contained inaccurate information regarding recurrence and association with open investigations.

Company
Beckman Coulter, Inc.
Inspection date
June 2, 2011
Product type
Devices
Office
Department of Health and Human Services
People
  • Emma R. Singleton (District Director)
  • Robert B. Hurley
  • Andrea H. Norwood (Investigator )
View Company Profile

ID · 1cd3da3d-4c0e-4104-92ce-6e3cefbd5926

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 U.S.C. 352(t)(2)21 U.S.C. 360i21 CFR 82021 CFR 820.100(a)21 CFR 820.198(a)21 CFR 820.25(b)21 CFR 80321 CFR 803.17

Full citation text and observation details available on the Dashboard.

Other documents for Beckman Coulter, Inc.
  • WARNING_LETTER - 2011-05-12May 12, 2011

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Beckman Coulter, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.